Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ by Allen, Rodger A, Brookings, Daniel C, Powell, Mark J, Delgado, Jean, Shuttleworth, Lindsay K, Merriman, Mark, Fahy, Ian J, Tewari, Roohi, Silva, John P, Healy, Louise J, Davies, Gareth C G, Twomey, Breda, Cutler, Rona M, Kotian, Apoorva, Crosby, Andrea, McCluskey, Gillian, Watt, Gillian F, Payne, Andrew

Get full text

Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells by Spender, Lindsay C, Ferguson, G John, Liu, Sijia, Cui, Chao, Girotti, Maria Romina, Sibbet, Gary, Higgs, Ellen B, Shuttleworth, Morven K, Hamilton, Tom, Lorigan, Paul, Weller, Michael, Vincent, David F, Sansom, Owen J, Frame, Margaret, Dijke, Peter Ten, Marais, Richard, Inman, Gareth J

Get full text

Impact of postoperative non-steroidal anti-inflammatory drugs on adverse events after gastrointestinal surgery by Chapman, S. J., Bhangu, A., Chaudhry, B., Clements, J. M., Robertson, K., Fadhlillah, M., Barker, T., Wright, T., Mohamad, W., Anderson, L. B., Brophy, T., Majumdar, S., Kauser, S., Carter, N., Horne, S., Allen, J. L. Y., Taylor, C., Satterthwaite, L., Hess, E. C. F., Finan, C., Ahmed, M., Grainger, C., Woo, A., Bulley, F., Aidoo‐Micah, G., Ellis, R., Kong, C. Y., Ochiltree, D. W., Hughes, M., Retchless, A. R., Bowley, D. M., Datta, U., Selby, J., Chandramoorthy, S., De Kauwe, C., Rana, R., Hill, M., Sagoo, H., Davis, J., Fillery, A., Watson, N. F., Marusza, C., Luck, J., Vaughan, R., Dean, S., Yap, D., Narramore, R., Walimohamed, S., Alsulaimi, A., Nepogodiev, D., Hernon, J., Flegg, K., Coley, J., Walls, M., Ban, V. S., Sait, S., Hawash, A., Shatkar, V., Moody, T., Shanthakumaran, S., Brodie, C., Winfield, S. Clayton A., Hosein, S., Cogbill, E., Shafi, A. M. A., Klimach, S., Flanigan, C., Shelton, B., Harvey, J., Pressler, N., Santos, C. R. D., Metcalfe, C., Mushtaq, J., Warren, M., Holohan, G., Strachan, E., Walsh, E., Mustafa, A., Barai, I., Soon, W. C., Patel, K., Mulla, A., Igbagiri, K. V., Navaratnam, J., Harrison, R., Hartelius, C. F., Lobo, R., Butters, T., Letchumanan, S., Koshnow, Z., Elamin, O., English, W., Brown, R. J., McCarter, J. A., Symonds, C., Jani, P., Trinquet, J., Jaffer, A., McAleer, E., Balian, V.

Get full text

P554 Vedolizumab Associated quality of Life and inflammatory bowel disease control Upon Entering a subcutaneous switching program (VALUE) – Results from a multi-centre UK study by Lim, S, Gros Alcade, B, Lehmann, A, Lindsay, J, Gaya, D, Caulfield, L, Dhar, A, Ritchie, S, Limdi, J, Taylor, J, Raine, T, Balendran, K, Shuttleworth, E, Kwok, J, Cococcia, S, Murray, C, Walker, G, Aldridge, R, George, B, Colbert, R, Dawson, P, Jameson, E, Irving, P, Sharma, E, Lees, C, Samaa, M

Get full text